ClinicalTrials.Veeva

Menu

Lead Mobilization & Bone Turnover in Pregnancy/Lactation

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status

Completed

Conditions

Lead Poisoning

Study type

Observational

Funder types

NIH

Identifiers

NCT00011726
7437-CP-001

Details and patient eligibility

About

We are examining the role of maternal bone lead turnover during pregnancy and lactation as a potential source of lead exposure for the fetus and the infant (via breast milk). A cohort, ascertained at entry to care, consists of >1000 women to be followed through pregnancy. In the postpartum subjects are recruited for a nested case control study to assess the influence of lactation on maternal bone density, maternal blood lead and breast milk lead.

Sex

Female

Ages

12 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

  1. Positive pregnancy test, age 12-35 and informed consent;
  2. Gestation <28 weeks at entry to prenatal care;
  3. No history of serious chronic or metabolic diseases, which could affect maternal growth or bone density;
  4. Not corticosteroid user or diagnosed use of illicit drugs;
  5. Eligible for lactation study: Ascertainment during or participation in the pregnancy study and a negative pregnancy test.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems